Literature DB >> 10585488

Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor.

K G Tanner1, J Kyte.   

Abstract

A recombinant fragment of the human receptor for epidermal growth factor containing both its extracellular domain and its membrane-spanning segment, when dissolved with Triton X-100, was observed to dimerize in response to addition of epidermal growth factor (EGF) even at the lowest concentration of this fragment that could be assayed (4 nM). Consequently, the dissociation constant for the dimer of this fragment is at least 10,000-fold smaller than that for dimers of soluble, recombinant forms of the extracellular domain lacking the membrane-spanning segment. The second-order rate constant for dimerization of the fragment containing the extracellular domain and the membrane-spanning segment was estimated to be greater than 0.3 nM(-1) min(-1), more than 10-fold that of the native enzyme under the same conditions. This result suggests that the cytoplasmic domain of the intact enzyme sterically hinders its dimerization. When EGF is removed from the dimer of the fragment, the rate constant for its dissociation is greater than 0.2 min(-1), more than 40-fold that of the native enzyme. This result suggests that interfaces between cytoplasmic domains of intact EGF receptor impart significant stabilization to the dimer of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585488     DOI: 10.1074/jbc.274.50.35985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity.

Authors:  Goldi A Kozloski; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

Review 2.  Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.

Authors:  Edwin Li; Kalina Hristova
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

3.  In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib.

Authors:  Kazuko Sakai; Hideyuki Yokote; Kimiko Murakami-Murofushi; Tomohide Tamura; Nagahiro Saijo; Kazuto Nishio
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

4.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

5.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

6.  FGFR3 unliganded dimer stabilization by the juxtamembrane domain.

Authors:  Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Mol Biol       Date:  2015-02-15       Impact factor: 5.469

7.  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.

Authors:  Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima; Sei Shu; Nobuyuki Ishikura; Shunichi Ariizumi; Masakazu Yamamoto; Kunihiko Kurosaki; Junichi Shoda
Journal:  J Gastroenterol       Date:  2014-08-12       Impact factor: 7.527

8.  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Authors:  Chafen Lu; Li-Zhi Mi; Michael J Grey; Jieqing Zhu; Elizabeth Graef; Shigeyuki Yokoyama; Timothy A Springer
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

9.  Transmembrane peptides as inhibitors of ErbB receptor signaling.

Authors:  Amar Bennasroune; Maria Fickova; Anne Gardin; Sylvie Dirrig-Grosch; Dominique Aunis; Gérard Crémel; Pierre Hubert
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

10.  Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.

Authors:  Xiaochun Yu; Kailash D Sharma; Tsuyoshi Takahashi; Ryo Iwamoto; Eisuke Mekada
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.